Overview: Osmotic Fragility TestIntroduction: The Osmotic Fragility Test detects red blood cell (RBC) fragility to diagnose hemolytic anemia, causing fatigue or jaundice. Aligned with 2023 ASH guidelines, it uses hematological methods for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in hematology for patients with suspected hemolytic anemia, such as hereditary spherocytosis.
Other Names: RBC Fragility Assay, Erythrocyte Osmotic Test.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic accuracy.
Historical Milestone: Osmotic fragility testing began in the 1930s with RBC membrane studies. Methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects RBC fragility to diagnose hemolytic anemia, guides treatment, and evaluates patients with fatigue or jaundice.
Test Parameters: 1. RBC Osmotic Fragility
Pretest Condition: No fasting required. Collect whole blood. Report history of fatigue, jaundice, or anemia symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, jaundice, splenomegaly, or family history of hemolytic anemia. Include current medications, especially folate supplements.
Consent: Written consent required, detailing the tests purpose, hemolytic anemia implications, and risks of sample collection.
Procedural Considerations: Uses saline solutions to test RBC lysis under osmotic stress. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for hemolytic anemia diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or hemolysis can affect results. Recent transfusions may alter RBC fragility.
Clinical Significance: Increased fragility confirms hemolytic anemia, guiding splenectomy or folate therapy. Normal results may require genetic testing.
Specialist Consultation: Consult a hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Peripheral smear, reticulocyte count, or genetic testing to confirm hemolytic anemia diagnosis.
Test Limitations: Non-specific for certain hemolytic anemias; clinical correlation is needed. Sample quality affects sensitivity.
References: ASH Hemolytic Anemia Guidelines, 2023; Blood, Gallagher PG, 2022.
